dactinomycin has been researched along with Leukemia, Megakaryocytic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertoglio, J; Bréard, J; Issaad, C; Léglise, MC; Pallardy, M; Roger, R; Turhan, AG | 1 |
| Dang, Y; Fujita, Y; Kawasaki, K; Oka, S; Shang, X; Tsuruga, M; Yamazaki, Y; Zhou, D | 1 |
2 other study(ies) available for dactinomycin and Leukemia, Megakaryocytic
| Article | Year |
|---|---|
BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells.
Topics: Apoptosis; Camptothecin; Cycloheximide; Cytotoxicity, Immunologic; Dactinomycin; DNA Damage; DNA, Neoplasm; Etoposide; Fusion Proteins, bcr-abl; Hematopoietic Stem Cells; Humans; Hydrogen Peroxide; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Puromycin; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1996 |
Cytoskeletal disruption accelerates caspase-3 activation and alters the intracellular membrane reorganization in DNA damage-induced apoptosis.
Topics: Actins; Apoptosis; Calcium; Caspase 3; Caspase 9; Caspases; Cell Division; Cytoskeleton; Cytotoxins; Dactinomycin; DNA Damage; Electrophysiology; Enzyme Activation; Enzyme Precursors; Fluorescent Antibody Technique; Humans; In Situ Nick-End Labeling; Intracellular Membranes; Leukemia, Megakaryoblastic, Acute; Membrane Potentials; Microscopy, Confocal; Microscopy, Electron; Mitochondria; Organelles; Protein Synthesis Inhibitors; RNA; Tumor Cells, Cultured | 2000 |